- Home
- KBDC vs BLFS Comparison
KBDC vs BLFS Comparison
Compare KBDC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBDC
- BLFS
- Stock Information
- Founded
- KBDC 2021
- BLFS 1987
- Country
- KBDC United States
- BLFS United States
- Employees
- KBDC N/A
- BLFS N/A
- Industry
- KBDC
- BLFS Medical/Dental Instruments
- Sector
- KBDC
- BLFS Health Care
- Exchange
- KBDC Nasdaq
- BLFS Nasdaq
- Market Cap
- KBDC 1.2B
- BLFS 1.1B
- IPO Year
- KBDC N/A
- BLFS 1989
- Fundamental
- Price
- KBDC $15.92
- BLFS $21.88
- Analyst Decision
- KBDC Buy
- BLFS Strong Buy
- Analyst Count
- KBDC 5
- BLFS 7
- Target Price
- KBDC $16.60
- BLFS $30.57
- AVG Volume (30 Days)
- KBDC 126.5K
- BLFS 598.8K
- Earning Date
- KBDC 05-12-2025
- BLFS 05-08-2025
- Dividend Yield
- KBDC 11.94%
- BLFS N/A
- EPS Growth
- KBDC N/A
- BLFS N/A
- EPS
- KBDC N/A
- BLFS N/A
- Revenue
- KBDC N/A
- BLFS $87,762,000.00
- Revenue This Year
- KBDC $193.84
- BLFS $21.21
- Revenue Next Year
- KBDC $12.68
- BLFS $17.59
- P/E Ratio
- KBDC N/A
- BLFS N/A
- Revenue Growth
- KBDC N/A
- BLFS 34.80
- 52 Week Low
- KBDC $13.93
- BLFS $18.70
- 52 Week High
- KBDC $17.99
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- KBDC N/A
- BLFS 44.17
- Support Level
- KBDC N/A
- BLFS $21.48
- Resistance Level
- KBDC N/A
- BLFS $22.72
- Average True Range (ATR)
- KBDC 0.00
- BLFS 0.97
- MACD
- KBDC 0.00
- BLFS -0.05
- Stochastic Oscillator
- KBDC 0.00
- BLFS 16.67
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.